SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-23-000064
Filing Date
2023-10-05
Accepted
2023-10-05 08:30:34
Documents
14
Period of Report
2023-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20231004.htm   iXBRL 8-K 41818
2 EX-10.1 separationandconsultingagr.htm EX-10.1 82690
  Complete submission text file 0000899923-23-000064.txt   311048

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20231004.xsd EX-101.SCH 2140
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20231004_def.xml EX-101.DEF 15379
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20231004_lab.xml EX-101.LAB 29819
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20231004_pre.xml EX-101.PRE 16085
8 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20231004_htm.xml XML 3728
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 231309868
SIC: 2835 In Vitro & In Vivo Diagnostic Substances